Urticaria

Moshe Ben-Shoshan; Amin Kanani; Chrystyna Kalicinsky; Wade Watson

doi:10.1186/s13223-024-00931-6

Urticaria

Allergy Asthma Clin Immunol. 2024 Dec 9;20(Suppl 3):64. doi: 10.1186/s13223-024-00931-6.

Authors

Moshe Ben-Shoshan¹, Amin Kanani², Chrystyna Kalicinsky³, Wade Watson⁴

Affiliations

¹ Division of Pediatric Allergy, Clinical Immunology and Dermatology, Department of Pediatrics, McGill University Health Center, Montreal, QC, Canada. [email protected].
² Division of Allergy and Immunology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
³ Section of Allergy & Clinical Immunology, Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.
⁴ Division of Allergy, Department of Pediatrics, IWK Health Centre, Dalhousie University, Halifax, NS, Canada.

Abstract

Urticaria (hives) is a common disorder that may be associated with angioedema (swelling that occurs beneath the skin). It is generally classified as acute or chronic, and chronic urticaria is further classified as spontaneous or inducible Second-generation, non-sedating histamine type 1 (H1)-receptor antihistamines represent the mainstay of therapy for both acute and chronic urticaria. Second-line treatment for uncontrolled chronic urticaria includes omalizumab (a monoclonal anti-immunoglobulin E [IgE] antibody). In this article, we review the causes, diagnosis and management of urticaria (with or without angioedema).

Keywords: Acute urticaria; Chronic spontaneous urticaria; Chronic urticaria; Inducible urticaria; Urticaria.

Publication types

Review